Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

por Valero, Vicente, Pawlik, Timothy M, Anders, Robert A
Publicado 2015

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer

por Castrellon, Aurelio Bartolome, Pidhorecky, Ihor, Valero, Vicente, Raez, Luis Estuardo
Publicado 2017

Update on systemic treatment for newly diagnosed inflammatory breast cancer

por Chainitikun, Sudpreeda, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Publicado 2020

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

por Alhalabi, Omar, Soomro, Zaid, Sun, Ryan, Hasanov, Elshad, Albittar, Aya, Tripathy, Debu, Valero, Vicente, Ibrahim, Nuhad K.
Publicado 2021

Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature

por Abdayem, Pamela, Ghosn, Marwan, Valero, Vicente, Walters, Ronald, Arun, Banu, Murray, James L., Theriault, Richard, Frye, Debbie, Ibrahim, Nuhad K.
Publicado 2014

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer

por De Giorgi, Ugo, Mego, Michal, Scarpi, Emanuela, Giordano, Antonio, Giuliano, Mario, Valero, Vicente, Alvarez, Ricardo H., Ueno, Naoto T., Cristofanilli, Massimo, Reuben, James M.
Publicado 2019

Pathological complete response of adding targeted therapy to neoadjuvant chemotherapy for inflammatory breast cancer: A systematic review

por Chainitikun, Sudpreeda, Espinosa Fernandez, Jose Rodrigo, Long, James P., Iwase, Toshiaki, Kida, Kumiko, Wang, Xiaoping, Saleem, Sadia, Lim, Bora, Valero, Vicente, Ueno, Naoto T.
Publicado 2021

Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors

por Wheler, Jennifer J., Atkins, Johnique T., Janku, Filip, Moulder, Stacy L., Stephens, Philip J., Yelensky, Roman, Valero, Vicente, Miller, Vincent, Kurzrock, Razelle, Meric-Bernstam, Funda
Publicado 2016

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer

por Debeb, Bisrat G, Gong, Yun, Atkinson, Rachel L, Sneige, Nour, Huo, Lei, Gonzalez-Angulo, Ana Maria, Hung, Mien-Chie, Valero, Vicente, Ueno, Naoto T, Woodward, Wendy A
Publicado 2014

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

por Aapro, Matti, Boccia, Ralph, Leonard, Robert, Camps, Carlos, Campone, Mario, Choquet, Sylvain, Danova, Marco, Glaspy, John, Hus, Iwona, Link, Hartmut, Sliwa, Thamer, Tesch, Hans, Valero, Vicente
Publicado 2017

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast...

por Esteva, Francisco J, Wang, Jing, Lin, Feng, Mejia, Jaime A, Yan, Kai, Altundag, Kadri, Valero, Vicente, Buzdar, Aman U, Hortobagyi, Gabriel N, Symmans, W Fraser, Pusztai, Lajos
Publicado 2007

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes

por Su, Xiaoping, Malouf, Gabriel G, Chen, Yunxin, Zhang, Jianping, Yao, Hui, Valero, Vicente, Weinstein, John N, Spano, Jean-Philippe, Meric-Bernstam, Funda, Khayat, David, Esteva, Francisco J
Publicado 2014

Outcomes of children exposed in utero to chemotherapy for breast cancer

por Murthy, Rashmi K, Theriault, Richard L, Barnett, Chad M, Hodge, Silvia, Ramirez, Mildred M, Milbourne, Andrea, Rimes, Sue A, Hortobagyi, Gabriel N, Valero, Vicente, Litton, Jennifer K
Publicado 2014

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice

por Murthy, Rashmi K., Song, Juhee, Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Hess, Kenneth R., Barcenas, Carlos H., Valero, Vicente, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Publicado 2020

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

por Kida, Kumiko, Hess, Kenneth R., Lim, Bora, Iwase, Toshiaki, Chainitikun, Sudpreeda, Valero, Vicente, Lucci, Anthony, Le-Petross, Huong Carisa, Woodward, Wendy A., Krishnamurthy, Savitri, Hortobagyi, Gabriel N., Tripathy, Debu, Ueno, Naoto T.
Publicado 2020

A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2‐Negative Breast Cancer

por Lim, Bora, Song, Juhee, Ibrahim, Nuhad K., Koenig, Kimberly B., Chavez‐MacGregor, Mariana, Ensor, Joe E., Gomez, Jill Schwartz, Krishnamurthy, Savitri, Caudle, Abigail S., Shaitelman, Simona F., Whitman, Gary J., Valero, Vicente
Publicado 2020

Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients

por Cohen, Evan N., Jayachandran, Gitanjali, Gao, Hui, Peabody, Phillip, McBride, Heather B., Alvarez, Franklin D., Kai, Megumi, Song, Juhee, Shen, Yu, Willey, Jie S., Lim, Bora, Valero, Vicente, Ueno, Naoto T., Reuben, James M.
Publicado 2023

PIK3CA-activating mutations and chemotherapy sensitivity in stage II–III breast cancer

por Liedtke, Cornelia, Cardone, Luca, Tordai, Attila, Yan, Kai, Gomez, Henry L, Figureoa, Luis J Barajas, Hubbard, Rebekah E, Valero, Vicente, Souchon, Eduardo A, Symmans, W Fraser, Hortobagyi, Gabriel N, Bardelli, Alberto, Pusztai, Lajos
Publicado 2008